Efficient Photocatalytic Degradation of Tetracycline on the MnFe2O4/BGA Composite under Visible Light

Int J Mol Sci. 2023 May 27;24(11):9378. doi: 10.3390/ijms24119378.

Abstract

In this work, the MnFe2O4/BGA (boron-doped graphene aerogel) composite prepared via the solvothermal method is applied as a photocatalyst to the degradation of tetracycline in the presence of peroxymonosulfate. The composite's phase composition, morphology, valence state of elements, defect and pore structure were analyzed by XRD, SEM/TEM, XPS, Raman scattering and N2 adsorption-desorption isotherms, respectively. Under the radiation of visible light, the experimental parameters, including the ratio of BGA to MnFe2O4, the dosages of MnFe2O4/BGA and PMS, and the initial pH and tetracycline concentration were optimized in line with the degradation of tetracycline. Under the optimized conditions, the degradation rate of tetracycline reached 92.15% within 60 min, whereas the degradation rate constant on MnFe2O4/BGA remained 4.1 × 10-2 min-1, which was 1.93 and 1.56 times of those on BGA and MnFe2O4, respectively. The largely enhanced photocatalytic activity of the MnFe2O4/BGA composite over MnFe2O4 and BGA could be ascribed to the formation of type I heterojunction on the interfaces of BGA and MnFe2O4, which leads to the efficient transfer and separation of photogenerated charge carriers. Transient photocurrent response and electrochemical impedance spectroscopy tests offered solid support to this assumption. In line with the active species trapping experiments, SO4•- and O2•- radicals are confirmed to play crucial roles in the rapid and efficient degradation of tetracycline, and accordingly, a photodegradation mechanism for the degradation of tetracycline on MnFe2O4/BGA is proposed.

Keywords: boron-doped graphene aerogel; cooperative effect; manganese ferrite; peroxymonosulfate; tetracycline degradation.

MeSH terms

  • Anti-Bacterial Agents* / chemistry
  • Catalysis
  • Light
  • Photolysis
  • Tetracycline* / chemistry

Substances

  • Anti-Bacterial Agents
  • Tetracycline

Grants and funding

This research received no external funding.